Skip to main content

Advertisement

Log in

Assessing the accuracy of autofluorescence, chemiluminescence and toluidine blue as diagnostic tools for oral potentially malignant disorders—a clinicopathological evaluation

  • Original Article
  • Published:
Clinical Oral Investigations Aims and scope Submit manuscript

Abstract

Objectives

Early detection of oral cancer and their precursors is the key to reducing the high mortality rate attributable to oral cancer. A variety of new chair-side diagnostic tools are currently available that may enhance oral mucosal examination and facilitate the detection of benign and malignant disorders. The aim of this study was to investigate the accuracy of autofluorescence, chemiluminescence and toluidine blue (TBlue) when used in combination against conventional oral examination and surgical biopsy for the detection and assessing risk status of oral potentially malignant disorders.

Materials and methods

A total of 126 patients, with white, red and mixed white and red patches were included. Following a comprehensive oral examination, all patients underwent a standard protocol of autofluorescence, chemiluminescence and TBlue examination. A surgical biopsy was performed to assess oral epithelial dysplasia.

Results

Seventy patients had leukoplakia/erythroplakia and 44 had epithelial dysplasia. In relation to leukoplakia/erythroplakia, autofluorescence, chemiluminescence and TBlue showed a sensitivity of 87.1, 77.1 and 52.9 % and a specificity of 21.4, 26.8 and 67.9 %, respectively. For dysplasia cases, autofluorescence, chemiluminescence and TBlue showed sensitivity and specificity of 84.1, 77.3 and 56.8 % and 15.3, 27.8 and 65.8 %, respectively.

Conclusion

While all the three tests were useful in detecting oral mucosal changes, their accuracy in identifying oral potentially malignant disorders (OPMD) is questionable. However, in combination, the tests yielded better results, with improved specificity.

Clinical relevance

These research tools are helpful in specialist clinics but further studies are necessary to examine their role in screening in primary care settings.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. IARC monographs on the evaluation of carcinogenic risks to humans (2012) Personal habits and indoor combustions. A review of human carcinogens. Lyon, France: Vol 100 E; IARC Press

  2. Warnakulasuriya S (2009) Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 45:309–316

    Article  PubMed  Google Scholar 

  3. Ferlay J, Pisani P, Parkin DM (2004) GLOBOCAN 2002. Cancer incidence, mortality and prevalence worldwide. IARC Cancer Base (2002 estimates). IARC Press, Lyon

    Google Scholar 

  4. Cancer Research UK, UK Cancer incidence (2011) by Country Summary, January 2014

  5. Conway DI, Stockton DL, Warnakulasuriya KA, Ogden G, Macpherson LM (2006) Incidence of oral and oropharyngeal cancer in United Kingdom (1990-1999)—recent trends and regional variation. Oral Oncol 42(6):586–592

    Article  PubMed  Google Scholar 

  6. Mashberg A, Samit A (1995) Early diagnosis of asymptomatic oral and oropharyngeal squamous cancers. CA Cancer J Clin 45:328–351

    Article  PubMed  Google Scholar 

  7. Patton LL (2003) The effectiveness of community-based visual screening and utility of adjunctive diagnostic aids in the early detection of oral cancer. Oral Oncol 39:708–723

    Article  PubMed  Google Scholar 

  8. Sciubba J (1999) Improving detection of precancerous and cancerous oral lesions. J Am Dent Assoc 130:1445–1457

    Article  PubMed  Google Scholar 

  9. Tsantoulis PK, Kastrinakis NG, Tourvas AD et al (2007) Advances in the biology of oral cancer. Oral Oncol 43:523–534

    Article  PubMed  Google Scholar 

  10. Silverman S Jr (1988) Early diagnosis of oral cancer. Cancer 62:1796–1799

    Article  PubMed  Google Scholar 

  11. Warnakulasuriya S, Johnson NW, van der Waal I (2007) Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med 36:575–580

    Article  PubMed  Google Scholar 

  12. Patton LL, Epstein JB, Kerr AR (2008) Adjunctive techniques for oral cancer examination and lesion diagnosis: a systematic review of the literature. J Am Dent Assoc 139(7):896–905

    Article  PubMed  Google Scholar 

  13. Lingen MW, Kalmar JR, Karrison T, Speight PM (2008) Critical evaluation of diagnostic aids for the detection of oral cancer. Oral Oncol 44(1):10–22

    Article  PubMed Central  PubMed  Google Scholar 

  14. Awan KH, Morgan PR, Warnakulasuriya S (2011) Evaluation of an autofluorescence based imaging system (VELscope™) in the detection of oral potentially malignant disorders and benign keratoses. Oral Oncol 47(4):274–277

    Article  PubMed  Google Scholar 

  15. Awan KH, Morgan PR, Warnakulasuriya S (2011) Utility of chemiluminescence (ViziLite®) in the detection of oral potentially malignant disorders and benign keratoses. J Oral Pathol Med 40(7):541–544

    Article  PubMed  Google Scholar 

  16. Awan KH, Yang YH, Morgan PR, Warnakulasuriya S (2012) Utility of toluidine blue as a diagnostic adjunct in the detection of potentially malignant disorders of the oral cavity—a clinical and histological assessment. Oral Dis 18:728–733

    Article  PubMed  Google Scholar 

  17. Epstein JB, Oakley C, Millner A, Emerton S, van der Meij E (1997) The utility of toluidine blue application as a diagnostic aid in patients previously treated for upper oropharyngeal carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 83(5):537–547

    Article  PubMed  Google Scholar 

  18. Epstein JB, Feldman R, Dolor RJ, Porter SR (2003) The utility of tolonium chloride rinse in the diagnosis of recurrent or second primary cancers in patients with prior upper aerodigestive tract cancer. Head Neck 25(11):911–921

    Article  PubMed  Google Scholar 

  19. Onofre MA, Sposto MR, Navarro CM (2001) Reliability of toluidine blue application in the detection of oral epithelial dysplasia and in situ and invasive squamous cell carcinomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 91(5):535–540

    Article  PubMed  Google Scholar 

  20. Ram S, Siar CH (2005) Chemiluminescence as a diagnostic aid in the detection of oral cancer and potentially malignant epithelial lesions. Int J Oral Maxillofac Surg 34:521–527

    Article  PubMed  Google Scholar 

  21. Poh CF, Zhang L, Anderson DW, Durham JS, Williams M, Priddy RW, Berean KW, Ng SP, Tseng OL, MacAulay C, Rosin MP (2006) Fluorescence visualization detection of field alterations in tumour margins of oral cancer patients. Clin Cancer Res 22:12

    Google Scholar 

  22. Güneri P, Epstein JB, Kaya A, Veral A, Kazandı A, Boyacioglu H (2011) The utility of toluidine blue staining and brush cytology as adjuncts in clinical examination of suspicious oral mucosal lesions. Int J Oral Maxillofac Surg 40(2):155–161

    Article  PubMed  Google Scholar 

  23. Pavlova I, Williams M, El-Naggar A, Richards-Kortum R, Gillenwater A (2008) Understanding the biological basis of autofluorescence imaging for oral cancer detection: high-resolution fluorescence microscopy in viable tissue. Clin Cancer Res 14(8):2396–2404

    Article  PubMed Central  PubMed  Google Scholar 

  24. Huff K, Stark PC, Solomon LW (2009) Sensitivity of direct tissue fluorescence visualization in screening for oral premalignant lesions in general practice. Gen Dent 57(1):34–38

    PubMed  Google Scholar 

  25. Kerr AR, Sirois DA, Epstein JB (2006) Clinical evaluation of chemiluminescent lighting: an adjunct for oral mucosal examinations. J Clin Dent 17(3):59–63

    PubMed  Google Scholar 

  26. Huber MA, Bsoul SA, Terezhalmy GT (2004) Acetic acid wash and chemiluminescent illumination as an adjunct to conventional oral soft tissue examination for the detection of dysplasia: a pilot study. Quintessence Int 35(5):378–384

    PubMed  Google Scholar 

  27. Epstein JB, Silverman S Jr, Epstein JD, Lonky SA, Bride MA (2008) Analysis of oral lesion biopsies identified and evaluated by visual examination, chemiluminescence and toluidine blue. Oral Oncol 44(6):538–544

    Article  PubMed  Google Scholar 

  28. Oh ES, Laskin DM (2007) Efficacy of the ViziLite system in the identification of oral lesions. J Oral Maxillofac Surg 65:424–426

    Article  PubMed  Google Scholar 

  29. Rashid A, Warnakulasuriya S (2014) The use of light-based (optical) detection systems as adjuncts in the detection of oral cancer and oral potentially malignant disorders: a systematic review. J Oral Pathol Med. doi:10.1111/jop.12218

    PubMed  Google Scholar 

Download references

Acknowledgments

The device VELscope™ and Vizilite® plus kits were supplied free of charge by LED Diagnotics and Zila Inc., respectively. Dr. Derek Cooper, PhD, assisted in the statistical evaluation of data.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K. H. Awan.

Additional information

Awan holds a Ph.D degree from King’s College London and BDS from University of Karachi, Pakistan.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Awan, K.H., Morgan, P.R. & Warnakulasuriya, S. Assessing the accuracy of autofluorescence, chemiluminescence and toluidine blue as diagnostic tools for oral potentially malignant disorders—a clinicopathological evaluation. Clin Oral Invest 19, 2267–2272 (2015). https://doi.org/10.1007/s00784-015-1457-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00784-015-1457-9

Keywords

Navigation